Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT8009 in Patients With Nectin-4 Expressing Advanced Malignancies

NCT04561362 is registered in ClinicalTrials.gov with BicycleTx Limited as lead sponsor.

NCT NCT04561362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04561362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT8009 in Patients With Nectin-4 Expressing Advanced Malignancies
Lead sponsor
BicycleTx Limited
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
July 17, 2020
Completion date
December 31, 2026
Enrollment
329 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor, breast neoplasms, hormone receptor positive, her2-low neoplasms, hormone receptor positive, her2-negative neoplasms, non-small-cell lung neoplasms, ovarian neoplasm, triple negative breast neoplasms, urinary bladder neoplasm